Many association studies analyze the genotype frequencies of case and control data to predict susceptibility to diseases and cancers. Without providing the raw data for genotypes, many association studies cannot be interpreted fully. Often, the interactions of the single nucleotide polymorphisms (SNPs) are not addressed and this limits the potential of such studies. To solve these problems, we propose a novel computational method with source codes to generate a stimulated genotype dataset based on published SNP genotype frequencies. In this study we evaluate the combined effect of 26 SNP combinations related to eight published growth factor-related genes involved in carcinogenesis pathways of breast cancer. The genetic algorithm (GA) was chosen to provide simultaneous analysis of multiple independent SNPs. The GA can perform feature selection from different SNP combinations via their corresponding genotype (called the SNP barcode), and the approach is able to provide a specific SNP barcode with an optimized fitness value effectively. The best SNP barcode with the maximal occurrence difference between groups for the control and breast cancer, together with an odds ratio analysis, is used to evaluate breast cancer susceptibility. When they are compared to their corresponding non-SNP barcodes, the estimated odds ratios for breast cancer are less than 1 (about 0.85 and 0.87; confidence interval: 0.7473∼0.9585, p < 0.01) for specific SNP barcodes with two to five SNPs. Therefore, we were able to identify potential combined growth factor-related genes together with their SNP barcodes that were protective against breast cancer by in silico analysis.
Get full access to this article
View all access options for this article.
References
1.
Al-ZahraniA., SandhuM.S., LubenR.N.et al.2006. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum Mol Genet, 15:1–10.
2.
BassM.P., MartinE.R., HauserE.R.2004. Pedigree generation for analysis of genetic linkage and association. Pac Symp Biocomput, 93–103.
3.
BeaudetA.L., BelmontJ.W.2008. Array-based DNA diagnostics: let the revolution begin. Annu Rev Med, 59:113–129.
4.
BriollaisL., WangY., RajendramI.et al.2007. Methodological issues in detecting gene–gene interactions in breast cancer susceptibility: a population-based study in Ontario. BMC Med, 5:22.
5.
ChenX., SturgisE.M., El-NaggarA.K.et al.2008. Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers. Carcinogenesis, 29:2120–2125.
6.
ChengI., KrumroyL.M., PlummerS.J.et al.2007. MIC1 and IL1RN genetic variation and advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev, 16:1309–1311.
7.
DebK., AgrawalS., PratapA.et al.2002. A fast elitist non-dominated sorting genetic algorithm for multi-objective optimization: NSGA-II. IEEE Trans. Evol Comput, 6:182–197.
8.
DeviG.R., GrahamD.L., OhY.et al.2001. Effect of IGFBP-3 on IGF- and IGF-analogue-induced insulin-like growth factor-I receptor (IGFIR) signalling. Growth Horm IGF Res, 11:231–239.
9.
Dias AlexandreH.F., De VasconcelosJ.A.2002. Multiobjective genetic algorithms applied to solve optimization problems. IEEE Trans Magnet, 38:1133–1136.
10.
DunningA.M., EllisP.D., McBrideS.et al.2003. A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res, 63:2610–2615.
11.
FukudaR., HirotaK., FanF.et al.2002. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem, 277:38205–38211.
12.
GanZ.H., ChowT.W.S., HuangD.2008. Effective gene selection method using Bayesian discriminant based criterion and genetic algorithms. J Signal Process Syst, 50:293–304.
13.
GoodmanJ.E., MechanicL.E., LukeB.T.et al.2006. Exploring SNP–SNP interactions and colon cancer risk using polymorphism interaction analysis. Int J Cancer, 118:1790–1797.
14.
HancockD.B., MartinE.R., LiY.J.et al.2007. Methods for interaction analyses using family-based case-control data: conditional logistic regression versus generalized estimating equations. Genet Epidemiol, 31:883–893.
15.
HollandJ.1992. Adaptation in Nature and Artificial Systems. Cambridge, MA: MIT Press.
16.
HouE.S., AnsariN., RenH.1994. A genetic algorithm for multiprocessor scheduling. IEEE Trans Parallel Distrib Syst, 5:113–120.
17.
HuangS.F., ChenI.H., LiaoC.T.et al.2009. Combined effects of MDM2 SNP 309 and p53 mutation on oral squamous cell carcinomas associated with areca quid chewing. Oral Oncol, 45:16–22.
18.
KalmyrzaevB., PharoahP.D., EastonD.F.et al.2008. Hyaluronan-mediated motility receptor gene single nucleotide polymorphisms and risk of breast cancer. Cancer Epidemiol Biomarkers Prev, 17:3618–3620.
19.
KimS., ZhangB.T.2001. Evolutionary learning of web-document structure for information retrieval. 2001 Congress on Evolutionary Computation, 2:1253–1260.
20.
LiL., WeinbergC.R., DardenT.A.et al.2001. Gene selection for sample classification based on gene expression data: study of sensitivity to choice of parameters of the GA/KNN method. Bioinformatics, 17:1131–1142.
21.
LiM.O., FlavellR.A.2008. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity, 28:468–476.
22.
LiS., BasergaR.1996. Epidermal growth factor and platelet-derived growth factor regulate the activity of the insulin-like growth factor I gene promoter. Exp Gerontol, 31:195–206.
23.
LinG.T., TsengH.F., YangC.H.et al.2009. Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. OMICS, 13:165–172.
24.
LiuJ.J., CutlerG., LiW.et al.2005. Multiclass cancer classification and biomarker discovery using GA-based algorithms. Bioinformatics, 21:2691–2697.
25.
LiuY., ScheurerM.E., El-ZeinR.et al.2009. Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev, 18:204–214.
26.
MooreS.C., LeitzmannM.F., WeinsteinS.J.et al.2007. Insulin resistance-related gene polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev, 16:1315–1317.
ParkY.H., SohnS.K., KimJ.G.et al.2009. Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy. Clin Cancer Res, 15:2107–2115.
29.
PatelA.V., ChengI., CanzianF.et al.2008. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3)PLoS ONE, 3:e2578.
30.
PetersenD.C., SeveriG., HoangH.N.et al.2008. No association between common chemokine and chemokine receptor gene variants and prostate cancer risk. Cancer Epidemiol Biomarkers Prev, 17:3615–3617.
31.
PharoahP.D., TyrerJ., DunningA.M.et al.2007. Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet, 3:e42.
32.
PngA.E., ChooK.W., LeeC.I.et al.2006. Primer design for Whole Genome Amplification using genetic algorithms. In Silico Biol, 6:505–514.
33.
PopandaO., SchattenbergT., PhongC.T.et al.2004. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis, 25:2433–2441.
34.
PoulakiV., MitsiadesC.S., McMullanC.et al.2003. Regulation of vascular endothelial growth factor expression by insulin-like growth factor I in thyroid carcinomas. J Clin Endocrinol Metab, 88:5392–5398.
35.
PullanW.2003. Adapting the genetic algorithm to the traveling salesman problem. CEC ‘03. The 2003 Congress on Evolutionary Computation, 2:1029–1035.
36.
SchabathM.B., WuX., WeiQ.et al.2006. Combined effects of the p53 and p73 polymorphisms on lung cancer risk. Cancer Epidemiol Biomarkers Prev, 15:158–161.
37.
SchmidtM., HauserE.R., MartinE.R.et al.2005. Extension of the SIMLA package for generating pedigrees with complex inheritance patterns: environmental covariates, gene–gene and gene–environment interaction. Stat Appl Genet Mol Biol, 4Article15.
38.
SmithT.R., LevineE.A., FreimanisR.I.et al.2008. Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis, 29:2132–2138.
39.
StevensV.L., RodriguezC., SunJ.et al.2008. No association of single nucleotide polymorphisms in one-carbon metabolism genes with prostate cancer risk. Cancer Epidemiol Biomarkers Prev, 17:3612–3614.
40.
SubramanianA., SharmaA., MokbelK.2008. Insulin-like growth factor binding proteins and breast cancer. Breast Cancer Res Treat, 107:181–194.
41.
SunJ., ChangB.L., IsaacsS.D.et al.2008. Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations. Prostate, 68:1257–1262.
42.
TangY., ZhangD., FallavollitaL.et al.2003. Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor. Cancer Res, 63:1166–1171.
43.
TremollieresF.A., StrongD.D., BaylinkD.J.et al.1991. Insulin-like growth factor II and transforming growth factor beta 1 regulate insulin-like growth factor I secretion in mouse bone cells. Acta Endocrinol (Copenh), 125:538–546.
44.
TsaiC.F., TsaiC.W., ChenC.P.et al.2002. A multiple-searching approach to genetic algorithms for solving traveling salesman problem. Joint Conference on Information Sciences, 362–366.
45.
VaaralaM.H., MattilaH., OhtonenP.et al.2008. The interaction of CYP3A5 polymorphisms along the androgen metabolism pathway in prostate cancer. Int J Cancer, 122:2511–2516.
46.
VafaieH., De JongK.1992. Genetic algorithms as a tool for feature selection in machine learning. Proceeding of the 4th International Conference on Tools with Artificial Intelligence, 200–203.
47.
YenC.Y., LiuS.Y., ChenC.H.et al.2008. Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. J Oral Pathol Med, 37:271–277.
48.
YuanX., ZhouG., ZhaiY.et al.2008. Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev, 17:3621–3627.
49.
ZhangJ., YuK.F.1998. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA, 280:1690–1691.
50.
ZhengS.L., SunJ., WiklundF.et al.2008. Cumulative association of five genetic variants with prostate cancer. N Engl J Med, 358:910–919.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
